Business Description
Quoin Pharmaceuticals Ltd
NAICS : 541715
SIC : 2834
ISIN : US74907L3006
Share Class Description:
QNRX: ADRDescription
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.47 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 35 | |||||
| 3-Year EPS without NRI Growth Rate | 36.5 | |||||
| 3-Year FCF Growth Rate | 30.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 79.71 | |||||
| 9-Day RSI | 64.99 | |||||
| 14-Day RSI | 48 | |||||
| 6-1 Month Momentum % | -80.49 | |||||
| 12-1 Month Momentum % | -86.46 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.15 | |||||
| Quick Ratio | 3.15 | |||||
| Cash Ratio | 2.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -160.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -107.32 | |||||
| ROA % | -56.52 | |||||
| ROIC % | -938.84 | |||||
| ROCE % | -79.64 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.14 | |||||
| Price-to-Tangible-Book | 0.15 | |||||
| EV-to-EBIT | 0.86 | |||||
| EV-to-EBITDA | 0.87 | |||||
| EV-to-FCF | 0.99 | |||||
| Price-to-Net-Current-Asset-Value | 0.16 | |||||
| Price-to-Net-Cash | 0.19 | |||||
| Earnings Yield (Greenblatt) % | 116.28 | |||||
| FCF Yield % | -270.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:QNRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Quoin Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -10.3 | ||
| Beta | 0 | ||
| Volatility % | 93.35 | ||
| 14-Day RSI | 48 | ||
| 14-Day ATR ($) | 0.070648 | ||
| 20-Day SMA ($) | 0.71325 | ||
| 12-1 Month Momentum % | -86.46 | ||
| 52-Week Range ($) | 0.6029 - 12 | ||
| Shares Outstanding (Mil) | 3.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Quoin Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Quoin Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Quoin Pharmaceuticals Ltd Frequently Asked Questions
What is Quoin Pharmaceuticals Ltd(QNRX)'s stock price today?
The current price of QNRX is $0.79. The 52 week high of QNRX is $12.00 and 52 week low is $0.60.
When is next earnings date of Quoin Pharmaceuticals Ltd(QNRX)?
The next earnings date of Quoin Pharmaceuticals Ltd(QNRX) is 2024-05-22 Est..
Does Quoin Pharmaceuticals Ltd(QNRX) pay dividends? If so, how much?
Quoin Pharmaceuticals Ltd(QNRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers